IMAAVY Solution (Janssen Inc), DIN 02563509, 300 mg/1.62 mL, lots JNYJ1202 and JNYJ1206, distributed nationally in Canada is affected. The lots were recalled because they may contain glass particles; verify if your product is one of the affected lots, consult your healthcare provider for any health concerns, contact the recalling firm with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Healthcare Establishments
Companies: Janssen Inc 19 Green Belt Drive Toronto Ontario.
How to identify it
Brand: Janssen Inc; Product Name: IMAAVY; Market Authorization: DIN 02563509; Dosage Form: Solution; Strength: 300 mg/ 1.62 mL; Lot Number: JNYJ1202, JNYJ1206
The hazard
Affected lots may contain glass particles.
What to do
Verify if your product is affected.
Consult your healthcare provider for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
Where it was sold
National
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)